Screen for 50+ cancer types with one blood test ¹

The Hims Multi-Cancer Test by Galleri® is a simple annual screen that analyzes DNA fragments in your blood to detect a signal linked to 50+ cancer types not commonly tested for, including lung, pancreatic, and liver.¹ The signal indicates potential cancer cells present in your body at the time of testing, allowing you to proactively check for a signal of 50+ cancers, potentially before symptoms appear.

If a Cancer Signal is found, the test will predict the likely area of origin in your body.

The test does not detect a signal for all cancers, and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri® test should be used in addition to healthcare provider-recommended screening tests. 1. In a clinical study, the Galleri® test detected a signal shared by more than 50 types of cancer. Not all 50+ cancers occur in both males and females. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806

Men face cancers that can develop silently and be missed in early stages, like lung, pancreatic, and liver.² About 1 in 2 men will develop invasive cancer in their lifetime,³ while recommended screenings cannot detect more than 81% of men’s cancers.⁴

Early detection can make a meaningful difference. When colon and rectum cancer is found earlier vs. after it has spread to other organs, the five-year survival rate can improve from 15.2% to 90.7%.⁵

2. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806

3. According to the National Cancer Society based on data obtained between 2017-2019. American Cancer Society. (2024). Cancer Facts & Figures. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2024/2024-cancer-facts-and-figures-acs.pdf

4. Based on estimated new cancer cases in the US in 2024 and USPSTF recommendations. Figure includes colorectal cancers and some lung and bronchus cancers but excludes prostate cancer based on the USPSTF recommendation that prostate cancer screening should be an individual one. American Cancer Society. (2024). Cancer Facts & Figures. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2024/2024-cancer-facts-and-figures-acs.pdf

5. Based on data from 2015–2021 from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. “Earlier” refers to localized cancer that is confined to the primary site; “after it has spread to other organs” refers to distant cancer that has metastasized. The Galleri test has not yet been shown to reduce deaths due to cancer or improve overall survival. Colon and Rectum (including Appendix) SEER 5-Year Relative Survival Rates, 2015-2021. SEER. (n.d.). https://seer.cancer.gov/statistics-network/explorer/application.html?site=20&data_type=4&graph_type=5&compareBy=stage&chk_stage_104=104&chk_stage_105=105&chk_stage_106=106&chk_stage_107=107&series=9&sex=2&race=1&age_range=1&advopt_precision=1&advopt_show_ci=on#resultsRegion0

The Hims Multi-Cancer Test by Galleri® is just like any other blood draw: happening just once a year and taking only a few minutes to perform.

Book your appointment at one of 2,000+ Quest Diagnostics locations directly through the Hims app.

You’ll get step-by-step guidance along the way and will be notified when results are available. If a Cancer Signal is detected, a provider will contact you as soon as possible, typically within 15 hours, to discuss your results.

In a clinical study, the Hims Multi-Cancer Test by Galleri® detected a signal shared by more than 50 types of cancer, including lung, pancreatic, and liver.⁶ You can see the full list of cancers here.

The Galleri® test does not detect a signal for all cancers, and not all cancers can be detected in the blood. Galleri® is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.

6. Not all 50+ cancers occur in both males and females. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806

No, the Hims Multi-Cancer Test by Galleri® is not diagnostic. If a Cancer Signal is detected, further diagnostic testing in person is needed to confirm cancer. The test does not detect a signal for all cancers, and not all cancers can be detected in the blood. False positive and false negative results do occur. We recommend talking to your healthcare provider to determine if additional testing is needed.

No, the Hims Multi-Cancer Test by Galleri® is a point-in-time test that identifies DNA in the bloodstream shed by cancer cells present.

You’ll be notified once your results are available. Your results will either indicate Cancer Signal Detected or No Cancer Signal Detected.

If a Cancer Signal is detected, it’s not a cancer diagnosis. A provider will contact you as soon as possible, typically within 15 hours, to discuss your results. Your results will include a prediction of the tissue type or organ associated with the Cancer Signal, called a Cancer Signal Origin.

For next steps, we recommend that you download and share your results with your in-person healthcare provider, who may suggest further testing and imaging. If you don't have a healthcare provider, you have access to call a Galleri® Patient Advocate. You can also email patient-advocate@GRAILbio.com to set up a time to speak with an advocate.

A Cancer Signal Detected result doesn’t mean you have cancer, but it does indicate the need for further evaluation. If a Cancer Signal is detected, a provider will contact you as soon as possible, typically within 15 hours, to discuss your results. You’ll be notified when results are available.

For next steps, we recommend that you download and share your results with your in-person healthcare provider, who may suggest further testing and imaging. If you don't have a healthcare provider, you have access to call a Galleri® Patient Advocate. You can also email patient-advocate@GRAILbio.com to set up a time to speak with an advocate.

This result doesn’t completely rule out the possibility of cancer. While the Galleri® test is a powerful tool, it cannot detect a signal for all cancers, and not all cancers can be detected in the blood. Some cancers shed little or no DNA into the bloodstream, making them unlikely to be detected through a blood test. False positive and false negative results do occur. This result does not predict whether you will develop cancer in the future.

It’s recommended to perform the Hims Multi-Cancer Test by Galleri® annually. Cancer can develop at any time. Even if no Cancer Signal is found at the time you take the test, changes in your body can occur over time, and having regular checkups can help you stay ahead.

Insurance isn’t required, so there are no complicated insurance questions or health insurance plan considerations.

You’ll be able to add the Hims Multi-Cancer Test by Galleri® onto your Labs by Hims plan after answering a few questions to ensure you’re eligible. Then, it’s easy to book your blood draw appointment at a Quest Diagnostics location near you directly through the Hims app. Your appointment will take just a few minutes.

You’ll get a Cancer Signal Detected or No Cancer Signal Detected result with clear next steps and guidance. If a Cancer Signal is detected, a provider will contact you as soon as possible, typically within 15 hours, to discuss your results.